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External Quality Control for
Radioimmunoassay of Urinary
Albumin in Diabetic Subjects: A
One-Year Experience
To the Editor:
In diabetic populations, who have
an increased prevalence of hyperten-
sion and renal disease, the assay of
urinary albumin excretion (UAE) has
assumed an important role in the pre-
vention and monitoring of diabetic
nephropathy and in the evaluation of
cardiovascular risk (1-4). Because
screening for microalbuminuria has
become part of routine diabetes care
and involves an increasing number of
patients, a suitable and standardized
method should be used for measuring
albumin in urine. To meet these
needs, one must know and try to mm-
imize all analytical sources of varia-
tion and error. Although several im-
munological procedures (such as
enzyme immunoassay, immunotur-
bidimetric assay, fluoroimmunoassay,
and immunonephelometric assay) have
been widely used for routine measure-
ment of UAE, radioimmunoassay is
generally considered the most reliable
method (5, 6). Because external quality
assessment (EQA) programs contrib-
ute to improving the analytical perfor-
mances of participating laboratories
through the comparison oftheir results
with those produced by others, our lab-
oratory, starting in March 1988, orga-
nized a national pilot EQA program for
urinary albumin RIA to estimate the
variability among and within laborato-
ries in Italy as well as to check the
possibility of improving, by an EQA
survey, laboratory performance in
measuring microalbuminuria. Here,
we report results from the first year of
this program.
The EQA scheme was based on the
distribution of frozen pooled urine
samples, followed by the computerized
analysis of the returned results, as
previously described (7-9). Partici-
pant laboratories assayed quality con-
trol (QC) samples by their routine pro-
cedures, returning results with the
name of the method or kit used. After
collected results had been processed by
computer, summaries were prepared
and sent back to each participant. Two
EQA cycles have been accomplished
(each cycle lasts -6 months). Fifteen
laboratories took part in the EQA pro-
gram (11 in the first phase). Only two
kits were used by the 15 participant
laboratories: Albumin RIA 100, sup-
plied by Pharmacia (Uppsala, Sweden;
n = 8; n = 6 in the first phase), and
H-Albumin, by Sclavo (Ciisello Bal-
samo, Milano, Italy; n = 7; n = 5 in the
first phase).
We prepared 450 QC samples from
13 urine pools to be sent to partici-
pants in the two cycles. During the
first one, we mailed out, in five dis-
patches, 165 QC specimens to 1 1 lab-
oratories (Table 1). All these samples
had been prepared from three urine
pools (pools 1, 2, and 3) with low (con-
sensus mean = 5.2 ± 0.95 mgIL), me-
dium (23.6 ± 3.3 mgfL), and high (59.3
± 8.1 mg/L) albumin concentrations.
During the second cycle, we sent 285
QC vials derived from 10 urine pools:
three pools had been set up by adding
to a low-albumin pool weighed
amounts of human albumin (pools 4,
5, and 6), and four pools had been
prepared by progressive dilution of a
high-albumin pool (pools 7, 8, 9, and
10). These seven pools were prepared
to better evaluate the accuracy of par-
ticipating laboratories, because the to-
tal variability found in the first cycle
was surprisingly large (CVs from 48%
to 66%). The last three pools derived
from urine samples with low (consen-
sus mean = 3.9 ± 1.3 mg/L), medium
(19.5 ± 2.9 mgIL), and high (52.9 ± 8.7
mg/L) albumin contents (pools ii, 12,
Table 1 . One-Factor Analysis of Variance of 1 45 UrInary Albumin Determinations In the First Cycle of the EQA
Survey and of 175 Urinary Albumin Determinations In the Second Cycle
cv, % Wfthln-kft cv, %
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and 13; Table 1). All urine samples
used for QC sample preparation were
negative for bacterial growth and con-
tamed sodium azide (-2 mL of a 200
g/L solution per liter of urine). Pre-
pared QC aliquots were frozen at
-20 #{176}Cuntil sent to participants,
packed in solid CO2 in polystyrene
containers.
All results collected in each EQA
cycle were used to compute (7-9) the
great or general mean (for each pool),
the consensus mean (for each pool),
laboratory bias, laboratory precision,
and total variability or between-lab
agreement (CV) and components of
variability. We also calculated the
outhier results by two statistical ap-
proaches, the target-value method and
the Cochran-Grubbs test (10). For the
target-value method, throughout each
phase of the survey, we considered as
outliers all the values that were >2
SD from the means of the RIA results
provided by our laboratory (target vah-
ues). During the first cycle ofthe EQA
program, pools 1, 2, and 3 were tested
42, 42, and 28 times, respectively, by
our laboratory in different experimen-
tal sessions. In the second phase, pools
11, 12, and 13 were measured 55, 51,
and 47 times, respectively, in different
sessions.
The consensus means calculated af-
ter deletion of outliers by the Coch-
ran-Grubbs test were very similar to
the means obtained after exclusion of
outliers by the target method, except
for QC pool 3. The sequential applica-
tion of the Cochran-Grubbs test al-
lowed the removal of three haborato-
ries in the first phase (one for pool 2
and two for pool 3) and none in the
second phase of EQA. A significant
decrease of variability between the
first and the second EQA phases was
also confirmed by the reduction of out-
her results as calculated by the target-
value method: 62 of 145 results (42%)
of the first phase and 46 of 278 results
(16.5%; P <0.001) of the second phase
were >2 SD of the target values.
The total variability (CVT) of urine
pools 1, 2, and 3, sent during the first
phase ofEQA, was very large, ranging
from 48% to 66%. The within-kit and
the between-kit components of van-
ability were quite similar, thus mdi-
cating that both the imprecision of the
two RIA kits and the between-kit dif-
ference were important causes of the
high urinary albumin assay impreci-
sion in that EQA phase (Table 1). In
four laboratories, the mean bias
showed a systematic deviation from
the consensus mean, whereas in two
other laboratories, the confidence him-
its of the mean appeared extremely
wide. Results from these six laborato-
ries accounted for the large number of
outliers found in the first phase of the
EQA program.
The analysis ofthe recovery and the
dilution tests showed good results for
11 of 15 laboratories. Two laboratories
had poor results for both the recovery
(mean of the absolute values of the
percent deviations from the expected
values >20%) and the dilution tests
(intercept significantly different from
zero). Two other laboratories had poor
results only for the recovery test.
These four laboratories accounted for
>50% of the outliers. The total van-
ability remained very large for pooh 11
(48%), but was substantially lower for
pools 12 and 13 compared with CVT
observed for similar pools in the first
EQA phase (pools 2 and 3, Table 1).
Regardless of the albumin concentra-
tion, the between-kit component of the
variability was lower in the second
(<10%) than in the first phase (30-
50%) of the EQA; no differences were
observed for results obtained with the
two kits.
Laboratories with both accuracy
and precision >25% improved their
performances substantially during the
second phase ofthe EQA survey (4/11
vs 12/15; chi-square = 5.10;P = 0.024)
for assays of urine samples with me-
dium and high albumin concentra-
tions.
A prerequisite for the EQA program
is the stability of EQA specimens
throughout the study. We previously
reported the stability over time of
urine pools at -20 #{176}C(as long as 6
months) (11) and after repeated freez-
ing and thawing (as many as five
times) (12). Stability of EQA samples
was also confirmed by repeatedly mea-
swing them in the reference labora-
tory throughout the two phases of the
study. These data agree with others,
indicating that urine samples are rel-
atively stable for several months at
-20 #{176}C(6).
A very high variability (from 40% to
60%) emerged from the first phase of
the EQA program. This finding was
surprising because RJA of urinary al-
bumin is generally considered so ro-
bust, easy to perform, and reliable
that it is suggested as the standard
technique for UAE determination (5,
6). All participant laboratories mea-
sured UAE by only two commercial
ifiA kits. Conceivably, if laboratories
using other RIAs or other methods
(such as nephelometnic or turbidimet-
nc assay) had participated in the EQA
scheme, the between-lab agreement
would have been worse, because sig-
nificant biases have been found among
the different methods currently used
for UAE (5, 6).
The total variability significantly
improved in the second phase of the
EQA survey, especially for albumin
concentrations in the medium and
high range. A large reduction in the
between-kit component occurred too.
Evidence consistent with ours was re-
cently provided by a study (13) de-
signed to check the existing variabil-
ity in the measurement of albumin in
urine among five laboratories using
various immunoassays (enzyme im-
munoassay, immunoturbidimetnic as-
say, fluorescent immunoassay, and
zone immunoelectrophoresis assay).
Results from this study indicated con-
siderable variation both within and
among laboratories; variability was
equally attributable to imprecision
and relative inaccuracy, being partic-
ularly high for materials with low
albumin concentrations (13).
In conclusion, our data indicate that
urinary albumin assays need to be ad-
equately standardized, and an external
QC of the assay is necessary even for
laboratories that use a common assay
procedure (such as RIA). Actually, the
interlaboratory survey is the only way
to quantitatively evaluate the perfor-
mance of an RJA. The improvement in
urinary albumin assay in the second
EQA period was particularly relevant
because it was obtained for those un-
nary albumin concentrations generally
considered of high clinical useflulness
for classifying diabetic people accord-
ing to well-established risk categories
for diabetic nephropathy and early car-
diovascular mortality.
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Monitoring NutrItIonal Status In
Burn Patients
To the Editor:
Rettmer et al. (1) compared the per-
formance of several static measure-
ments of serum concentrations with
some functional tests for the nub-i-
tional assessment of burn patients.
Although their conclusion that func-
tional tests generally provide a more
accurate evaluation of nutritional sta-
tus is probably correct, their interpre-
tation of their results is questionable.
To compare these two categories of
tests, the nutritional status of the
studied patients must be known. The
authors classified all their patients as
nutritionally replenished, this judg-
ment being based on the estimated
calories met, the weight change, and
the nitrogen balance. However, these
three characteristics reflect only the
protein and caloric nutritional status.
They do not necessarily indicate that
concentrations of all trace minerals
and vitamins are normal. Further-
more, these measures are also limited
as markers ofprotein-calorie status in
burn patients (2, 3). For example, one
of their patients achieved only 46% of
his estimated calorie needs but was
nonetheless considered to have been
adequately fed. Weight gain is diffi-
cult to interpret in burn patients be-
cause they can develop considerable
edema, which accounts for the greater
part of the weight gain in the first
weeks after the burn. In calculating
the nitrogen balance, Rettmer et al.
did not account for the losses of protein
in burn wounds, which can amount to
several grams per day (4).
The authors did not mention the
composition of the diet. There is great
diversity in the practices of burn cen-
ters concerning supplementation with
trace minerals and vitamins (5, 6).
Because Rettmer et al. did not evalu-
ate the same nutrients with the static
and the functional tests, we cannot be
sure whether the differences they ob-
served only reflect an insufficient sup-
plementation of some elements.
The choice of some ofthe static tests
is also dubious. Even in ambulatory
patients, no one would judge the nub-i-
tional status by measuring singly the
serum concentration ofcalcium or iron.
A low serum concentration of calcium
must be interpreted in light of the al-
bumin concentration (7). Similarly, the
concentration of transferrin (or the
binding capacity of iron) must be
known before one can interpret a low
serum iron concentration. Also, the
units for transferrin in their Figure 1
should read gIL instead of mg/L. If we
take into account the low concentration
of binding proteins, the observed con-
centrations of iron and calcium are
probably in the low normal range. The
same phenomenon could explain the
“low” serum copper values obtained (8).
The serum concentration of caro-
tone can reflect the nutritional status
ofvitamin A only ifit is a major source
in the diet (9). Because their patients
were probably supplemented with the
vitamin and not the provitamin (caro-
tone), the low concentrations obtained
should have been expected.
Finally, their Figure 4 contains sev-
eral errors. The results of the func-
tional assays are presented in the form
of activity coefficients, which are di-
mensionless. The units indicated
(prnoh/L) are thus inappropriate. The
range ofthe zinc protoporphyrin/heme
ratio cannot be correct because no re-
sults below the mean are indicated.
Despite the above restrictions, I
agree with Rettmer et al. that there is
a great need to develop new nutrition-
al-assessment procedures.
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J_ Masse
The authors ofthe article referred to
comment:
To the Editor:
The comments of Masse underscore
the difficulty in determining the nutni-
tional status of burn patients (1). The
nutritional support our patients re-
ceived from day 1 post-burn consisted
of enteral feeding with one of two
standard 1 kcal/L formulas supple-
mented by central venous alimenta-
tion and a standard multivitamin
package if needed. By day 5 all pa-
tients were meeting 84% of their
estimated requirements. By day 15,
